10x Genomics Change in Accounts Payable 2018-2025 | TXG

10x Genomics change in accounts payable from 2018 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.

10x Genomics Change in Accounts Payable 2018-2025 | TXG

10x Genomics change in accounts payable from 2018 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.
Related Stocks
Company NameMarket
Cap
Veeva Systems (VEEV)$47.5B
Tempus AI (TEM)$14B
Doximity (DOCS)$12.7B
Hims & Hers Health (HIMS)$10.1B
IRhythm Technologies (IRTC)$5.4B
Hinge Health (HNGE)$4.5B
Inspire Medical Systems (INSP)$2.8B
Privia Health (PRVA)$2.7B
Heartflow (HTFL)$2.4B
Enovis (ENOV)$1.8B
Phreesia (PHR)$1.8B
Omnicell (OMCL)$1.5B
Schrodinger (SDGR)$1.5B
Azenta (AZTA)$1.4B
Clover Health Investments (CLOV)$1.4B
Claritev (CTEV)$1.2B
Evolent Health (EVH)$1.1B
Fulgent Genetics (FLGT)$666M
Zepp Health (ZEPP)$580M
Veradigm (MDRX)$525M
Standard BioTools (LAB)$485M
Talkspace (TALK)$469M
Butterfly Network (BFLY)$383M
Carlsmed (CARL)$346M
TruBridge (TBRG)$307M
Outset Medical (OM)$252M
SOPHiA GENETICS SA (SOPH)$244M
Health Catalyst (HCAT)$231M
Nyxoah SA (NYXH)$219M
KORU Medical Systems (KRMD)$203M